HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 3.05
Day range
kr 2.83 - kr 3.17
Year range
kr 2.31 - kr 5.23
Market cap
380.62M SEK
Avg Volume
962.95K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.80M | -29.09% |
Net income | -15.86M | 44.00% |
Net profit margin | — | — |
Earnings per share | -0.13 | 55.17% |
EBITDA | -15.78M | 29.12% |
Effective tax rate | 0.42% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 49.86M | -33.74% |
Total assets | 111.94M | -20.56% |
Total liabilities | 12.47M | -79.88% |
Total equity | 99.47M | — |
Shares outstanding | 126.84M | — |
Price to book | 3.90 | — |
Return on assets | -31.82% | — |
Return on capital | -36.58% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.86M | 44.00% |
Cash from operations | -21.69M | -15.48% |
Cash from investing | — | — |
Cash from financing | -395.00K | 80.00% |
Net change in cash | -22.41M | -9.54% |
Free cash flow | -16.60M | -312.98% |
About
Founded
1999
Website
Employees
11
